Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum

Publication date

2024

Authors

de Bruijn, Henriette S
Mashayekhi, Vida
Schreurs, Tom J L
van Driel, Pieter B A A
Strijkers, Gustav J
van Diest, P. J.ORCID 0000-0003-0658-2745ISNI 000000004213151X
Lowik, Clemens W G M
Seynhaeve, Ann L B
Ten Hagen, Timo L M
Prompers, Jeanine JORCID 0000-0002-4756-4474

Editors

Advisors

Supervisors

Document Type

Comment

Collections

Open Access logo

License

cc_by

Abstract

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging (Theranostics (2020) 10:5 (2436-2452) DOI: 10.7150/thno.37949)

Keywords

Pharmacology, Toxicology and Pharmaceutics (miscellaneous), Medicine (miscellaneous), Published Erratum

Citation

de Bruijn, H S, Mashayekhi, V, Schreurs, T J L, van Driel, P B A A, Strijkers, G J, van Diest, P J, Lowik, C W G M, Seynhaeve, A L B, Ten Hagen, T L M, Prompers, J J, van Bergen En Henegouwen, P M P, Robinson, D J & Oliveira, S 2024, 'Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging: Erratum', Theranostics, vol. 14, no. 3, pp. 1099-1100. https://doi.org/10.7150/thno.93248